|
|
|
|
|
|
|
|
|
|
  |
 |
  |
Bureau for Global Health
>> Regional Overview >> Global Health Overview Program Data Sheet
936-001 IR 1.1USAID OPERATING UNIT: Bureau for Global Health
PROGRAM TITLE: Population & Reproductive Health-New Technologies (Pillar: Global Health)
STRATEGIC OBJECTIVE AND NUMBER: Increased use by women and men of voluntary practices that contribute to reduced fertility, 936-001 IR 1.1 New and improved technologies and approaches for contraceptive methods and family planning identified, developed, tested, evaluated and disseminated.
STATUS: Continuing
PLANNED FY 2002 OBLIGATION AND FUNDING SOURCE: $47,173,000 CSH
PROPOSED FY 2003 OBLIGATION AND FUNDING SOURCE: $47,173,000 DA
INITIAL OBLIGATION: FY 1996 ESTIMATED COMPLETION DATE: FY 2013Summary: Major categories of assistance under this Intermediate Result include:
- developing and testing of new or improved contraceptive, HIV and sexually transmitted infection (STI) prevention technologies;
- undertaking long-term studies of contraceptive methods in field programs to understand their acceptability, effectiveness, and other health benefits;
- engaging in operations research to improve the access and quality of family planning and reproductive health services in a cost-effective manner;
- developing new strategies to provide information and services to hard-to-reach populations such as young people, men, post-abortion clients, etc.; and
- developing improved data collection techniques for monitoring and evaluating program performance.
Inputs, Outputs and Activities: FY 2002 Program: Research and development activities are typically multi-year efforts. In the area of contraceptive and microbicide research and development, FY 2002 funds will be used to support: (1) Phase II and III trials of a one-year vaginal ring; (2) a two-year single-rod implant for the delivery of hormonal contraception; (3) a new, inexpensive latex female condom; (4) one or more hormonal methods for men; (5) start-up of Phase I, II and III studies for several microbicides; (6) evaluation of the efficacy of the diaphragm to prevent sexually transmitted infection (STI); (7) a simple delivery system (Uniject) for injectable hormonal contraceptives; and (8) introduction of the natural family planning Standard Days Method (SDM) into several countries. In addition, studies will be implemented to test different strategies to increase male condom use, and understand the benefits of introducing female condoms among high-risk groups.
In addition, USAID will continue to fund multi-country studies to test the impact of improvements in information and counseling provided to clients on their contraceptive continuation rates; develop and test cost-effective strategies to reach youth with reproductive health information and services to change behaviors; test the impact of involving men in the antenatal period on STD/HIV preventive behaviors; and replication and validation of willingness-to-pay studies to increase sustainability of organizations. Programmatic research will focus on the development of a common framework among donors for assessing contraceptive security across countries. Contraceptive security exists when every person is able to choose, obtain and use quality contraceptives and condoms for HIV/AIDS prevention.
In the monitoring and evaluation area, USAID will continue to support the development and testing of approaches to monitor quality of care at service sites, client preferences and sustainability of family planning programs. USAID will also make two awards aimed at improving the collection, analysis, and presentation of data for use in planning, policymaking, managing, monitoring and evaluation of population, health and nutrition programs.
Planned FY 2003 Program: Most of the programs described for FY 2002 funding are multi-year efforts and will continue with FY 2003 funding. These include research and development related to a vaginal ring, a single rod implant for hormonal contraception, a new female condom, new microbicides, a new diaphragm to prevent STIs, injectable hormonal contraceptives and the introduction of a new natural family planning method. In addition, various multi-country studies discussed above will be continued as will monitoring and evaluation activities related to quality of care.
Family planning assistance agreements either already include or will include standard clauses to implement the Mexico City Policy, per the Presidential Document entitled "Memorandum of March 28, 2001 for the Acting Administrator of the United States Agency for International Development--Restoration of the Mexico City Policy," (Federal Register: March 29, 2001, Volume 66, Number 61, Pages 17301-17313) attached to Contract Information Bulletin 01-08 (R). Compliance with this policy is being monitored regularly through routine information systems.
Performance and Results: In the area of contraceptive development, a study of the effectiveness of the diaphragm against STIs was initiated; acceptability of a second-generation female condom was evaluated; studies of a one-size-fits-all diaphragm were completed; and a novel, simple natural method, the SDM, was developed and tested. Six microbicide compounds will move forward to the next stage of testing after their safety was demonstrated in initial clinical trials. The reliability of a model predicting willingness-to-pay for contraceptive services was confirmed, thus eliminating the need for case-by-case willingness-to-pay studies. Questions related to female genital cutting were introduced into the Demographic and Health Surveys. Studies of alternative methods of collecting data on socio-economic status established that a measure based on household assets was as accurate and less expensive than collecting expenditure data.
Assuming progress continues as expected, these investments will result in: the availability of more and better contraceptive choices for men and women, including widespread availability of the SDM; more effective microbicides; increased condom use for dual protection against unwanted pregnancy and STI/HIV infection; successful service delivery strategies for meeting the needs of underserved populations; and a better understanding of the impact of program investments.
Major Contractors and Grantees: (1) The Population Council; (2) Family Health International; (3) Eastern Virginia Medical School; (4) Georgetown University; (5) Program for Appropriate Technology in Health; (6) World Health Organization; (7) ORC Macro International - subcontractors include The Population Council and East-West Center Program on Population; (8) University of North Carolina - subcontractors include ORC Macro International, Tulane University, and John Snow Research and Training Institute; (9) U.S. Bureau of the Census; (10) LTG Associates, Inc. - subcontractors include TvT Associates, Inc.; and (11) other cooperating agencies, universities, research institutions, and host country organizations.
US Financing in Thousands of Dollars
936-0011 New and Improved technologies and approached for contraceptive methods and family planning identified, developed, tested, evaluated and disseminated CSH DA Through September 30, 2000 Obligations 0 220,048 Expenditures 0 177,167 Unliquidated 0 42,881 Fiscal Year 2001 Obligations 0 50,577 Expenditures 0 42,374 Through September 30, 2001 Obligations 0 270,625 Expenditures 0 219,541 Unliquidated 0 51,084 Prior Year Unobligated Funds Obligations 0 0 Planned Fiscal Year 2002 NOA Obligations 47,173 0 Total Planned Fiscal Year 2002 Obligations 47,173 0 Proposed Fiscal Year 2003 NOA Obligations 0 47,173 Future Obligations 0 150,529 Est. Total Cost 47,173 468,327
 |
|||
Last Updated on: May 29, 2002 |
